029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
DRE803直肠腺癌及边缘组织组合芯片,附病理分级、TNM和临床分期,73例/80点
点 数80例 数73
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:DRE803
 
直肠腺癌及边缘组织组合微阵列芯片,包含70例腺癌,10例边缘组织(其中7例与癌匹配),一块一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Rec
-Rectum
 
Malignant (I)
 
Malignant (IIA)
 
Malignant (IIC)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
Malignant (IIIC)
 
Malignant (IV)
 
NAT (*)
TISSUE  ARRAYS DRE803
1
2
3
4
5
6
7
8
9
10
A
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
B
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
C
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
D
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
E
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
F
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
G
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
H
REC
REC
REC
REC
REC
REC
REC
REC
REC
REC
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1146FRectumAdenocarcinoma1T2N1M0IIIAMalignantN
A2253MRectumMucinous adenocarcinoma1T2N0M0IMalignantN
A3340MRectumPapillary adenocarcinoma1T3N0M0IIAMalignantN
A4454FRectumAdenocarcinoma1T2N0M0IMalignantN
A5562FRectumAdenocarcinoma1T2N0M0IMalignantN
A6633FRectumMucinous adenocarcinoma2T3N0M0IIAMalignantN
A7742FRectumAdenocarcinoma1T3N2M0IIIBMalignantN
A8867FRectumAdenocarcinoma2T2N2M0IIIBMalignantN
A9958FRectumAdenocarcinoma1T3N1M0IIIBMalignantN
A101074FRectumAdenocarcinoma1T3N1M0IIIBMalignantN
B11152MRectumAdenocarcinoma1T3N0M0IIAMalignantN
B21256FRectumAdenocarcinoma2T4N1M0IIIBMalignantN
B31338MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
B41472MRectumAdenocarcinoma2T3N2M0IIIBMalignantN
B51538FRectumAdenocarcinoma2T3N2M0IIIBMalignantN
B61634FRectumAdenocarcinoma2T3N2M0IIIBMalignantN
B71740MRectumAdenocarcinoma2T3N2M0IIIBMalignantN
B81853MRectumAdenocarcinoma2T3N0M0IIAMalignantN
B91958FRectumAdenocarcinoma2T2N0M0IMalignantN
B102060MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
C12138MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
C22250FRectumAdenocarcinoma2T2N0M0IMalignantN
C32364FRectumMucinous adenocarcinoma2T3N0M0IIAMalignantN
C42471MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
C52560MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
C62638FRectumMucinous adenocarcinoma3T2N0M0IMalignantN
C72733MRectumMucinous adenocarcinoma2--3T3N1M0IIIBMalignantN
C82863MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
C92954FRectumAdenocarcinoma2T3N0M0IIAMalignantN
C103059FRectumAdenocarcinoma2T4N2M0IIICMalignantN
D13169MRectumAdenocarcinoma2T4N0M0IICMalignantN
D23262MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
D33351MRectumMucinous adenocarcinoma2T2N1M1IVMalignantN
D43440FRectumAdenocarcinoma2T3N0M0IIAMalignantN
D53559MRectumAdenocarcinoma1T2N0M0IMalignantN
D63657MRectumAdenocarcinoma2T3N1M0IIIBMalignantN
D73733FRectumAdenocarcinoma2T3N2M0IIIBMalignantN
D83871MRectumAdenocarcinoma2T3N2M0IIIBMalignantN
D93952FRectumAdenocarcinoma2T3N2M0IIIBMalignantN
D104052FRectumAdenocarcinoma2T3N2M0IIIBMalignantN
E14155MRectumAdenocarcinoma2T3N2M0IIIBMalignantN
E24270FRectumAdenocarcinoma2T2N0M0IMalignantN
E34329FRectumAdenocarcinoma2T3N2M0IIIBMalignantN
E44439FRectumSquamous cell carcinoma2T3N0M0IIAMalignantN
E54547FRectumAdenocarcinoma2T2N2M0IIIBMalignantN
E64664FRectumAdenocarcinoma2T1N0M0IMalignantN
E74760MRectumAdenocarcinoma2T3N0M0IIAMalignantN
E84859MRectumAdenocarcinoma2T2N0M0IMalignantN
E94959MRectumAdenocarcinoma2T2N0M0IMalignantN
E105053FRectumMucinous adenocarcinoma2T3N0M0IIAMalignantN
F15152FRectumAdenocarcinoma2T2N0M0IMalignantN
F25276FRectumAdenocarcinoma2T3N0M0IIAMalignantN
F35373MRectumAdenocarcinoma (sparse)*T2N0M0IMalignantN
F45464MRectumAdenocarcinoma2T3N0M0IIAMalignantN
F55541FRectumAdenocarcinoma2T3N2M0IIIBMalignantN
F65636FRectumAdenocarcinoma2T2N1M0IIIAMalignantN
F75749MRectumMucinous adenocarcinoma2T4N0M0IICMalignantN
F85883MRectumAdenocarcinoma2T3N0M0IIAMalignantN
F95962MRectumAdenocarcinoma2T2N0M0IMalignantN
F106064FRectumAdenocarcinoma2T4N0M0IICMalignantN
G16140FRectumAdenocarcinoma2T2N1M0IIIAMalignantN
G26254MRectumAdenocarcinoma2T4N0M0IICMalignantN
G36327MRectumAdenocarcinoma2--3T3N2M0IIIBMalignantN
G46442MRectumAdenocarcinoma2--3T3N1M0IIIBMalignantN
G56532FRectumMucinous adenocarcinoma3T3N0M0IIAMalignantN
G66651MRectumAdenocarcinoma3T3N2M0IIIBMalignantN
G76749FRectumMucinous adenocarcinoma3T2N0M0IMalignantN
G86858MRectumMucinous adenocarcinoma3T3N0M0IIAMalignantN
G96966MRectumAdenocarcinoma3T3N0M0IIAMalignantN
G107059FRectumAdenocarcinoma (sparse)*T2N0M0IMalignantN
H17158FRectumAdjacent normal rectum tissue of No. 9***NATN
H27272MRectumAdjacent normal rectal mucosa tissue of No. 14***NATN
H37352FRectumAdjacent normal rectum tissue of No. 39***NATN
H47464MRectumAdjacent normal rectum tissue of No. 54***NATN
H57536FRectumAdjacent normal rectum tissue of No. 56***NATN
H67634MRectumAdjacent normal rectum tissue***NATN
H77770FRectumAdjacent normal rectum tissue of No. 42***NATN
H87864FRectumAdjacent normal rectum tissue (chronic inflammation of rectal tissue sparse) of No. 60***NATN
H97968MRectumAdjacent normal rectum tissue***NATN
H108037MRectumAdjacent normal rectum tissue (chronic inflammation of rectal tissue sparse)***NATN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情